Frederick Larcombe

Frederick Larcombe

Plus aucun poste en cours

67 ans
Health Technology
Retail Trade
Commercial Services

Profil

Mr. Fred Larcombe, CPA, is a Principal at Crimson Partners, Chief Financial Officer at iBIO, Chief Financial Officer, Secretary & Director at Heartland Bridge Capital, Inc., Chief Financial Officer at The Riderwood Group, Inc., and Chief Financial Officer at Heartland Bridge Capital, Inc. (Private Equity).
Mr. Larcombe has served as Chief Financial Officer for: Xenomics, a developer of DNA diagnostic tests; FermaVir Pharmaceuticals, a pharmaceutical development company; MicroDose Technologies, a drug delivery device company; and Genesis Direct, an internet retailer.
He started his professional career with PriceWaterhouseCoopers (PwC).
Mr. Larcombe received his BS in Accounting from Seton Hall University, and is a graduate of the Management Development Program at Harvard Business School.

Postes actifs de Frederick Larcombe

Anciens postes connus de Frederick Larcombe

SociétésPosteFin
TOWERSTREAM CORPORATION Director of Finance/CFO 15/05/2017
TRIR WELL Director of Finance/CFO 25/10/2012
IBIO, INC. Director of Finance/CFO 03/05/2011
Voir l'expérience en détail de Frederick Larcombe

Formation de Frederick Larcombe

Seton Hall University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Frederick Larcombe

Relations

28

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
CARDIFF ONCOLOGY, INC.

Health Technology

IBIO, INC.

Health Technology

TRIR WELL

Health Technology

TOWERSTREAM CORPORATION

Communications

Entreprise privées3

Retail Trade

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Frederick Larcombe